Livzon Pharmaceutical Group Inc. Board and Committee Update

Bulletin Express03-01

Livzon Pharmaceutical Group Inc.* announced an update on its Board of Directors and their respective committee memberships. The Board comprises Executive Director Mr. Tang Yanggang (Vice Chairman), Non-executive Directors Mr. Zhu Baoguo (Chairman), Mr. Lin Nanqi, and Mr. Qiu Qingfeng, Employee Representative Director Ms. Ran Yongmei, and Independent Non-executive Directors Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie, and Ms. Wang Zhiyao.

The announcement sets out five committees: the Audit Committee, Remuneration and Assessment Committee, Nomination Committee, Strategy Committee, and Environmental, Social and Governance Committee. According to the published information, these committees include designated chairpersons and members among the above directors, with assignments denoted by “C” for Chairperson and “M” for Member.

Date of disclosure: 1 March 2026 (Zhuhai, China).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment